Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV thiamine for hypophosphatemic critically ill adults receiving enteral nutrition
ACTRN12619000121167Phase 2Completed
- Sponsor
- Royal Melbourne Hospital
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of thiamine in critical illness, hypophosphatemia and thiamine deficiency, sponsored by Royal Melbourne Hospital. Primary endpoint: Change in arterial blood lactate concentration. Started Mar 2019; status: completed.
02
Drugs
thiamine
03
Conditions
critical illnesshypophosphatemiathiamine deficiency
Beyond the preview
Go deeper on ACTRN12619000121167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000121167.